Aligos Therapeutics Inc. buy BiotechBee
Start price
03.03.24
/
50%
€1.06
Target price
30.04.26
€3.00
Performance (%)
-55.80%
End price
14.07.24
€0.47
Summary
This prediction ended on 14.07.24 with a price of €0.47. Massive losses of -55.80% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aligos Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Aligos Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aligos Therapeutics Inc. diskutieren
In the thread Trading Aligos Therapeutics Inc.
Stopped prediction by BiotechBee for Aligos Therapeutics Inc.
Aligos Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.47
14.07.24
14.07.24
€1.00
28.02.26
28.02.26
-8.43%
08.09.24
08.09.24
Could be very worthwhile Investment >20% year
